UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
YI
111, Inc.
There isn't enough reported data to score YI yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
YI Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
YI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
YI PE Valuation
YI has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
YI Forward outlook
There aren't enough analyst estimates for YI to show an outlook.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over YI on earnings quality, reporting a profit while its opponent remains loss making.
YI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.79 | -$0.51 |
| Q1 2026 | -$1.46 | -$0.27 |
| Q4 2025 | -$1.14 | -$0.01 |
| Q3 2025 | -$1.21 | +$3.29 |
| Q2 2025 | -$1.28 | +$4.58 |
| Q1 2025 | -$1.19 | +$5.45 |
| Q4 2024 | -$1.13 | +$5.84 |
| Q3 2024 | -$4.50 | +$0.68 |
YI is still losing money, but far less than before: $1.79 per share over the past year, against $12.49 at its worst in late 2021.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over YI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over YI on profitability, with a higher operating margin.
YI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $345.2M | -28% |
| Q1 2026 | $354.4M | -33% |
| Q4 2025 | $417.4M | -28% |
| Q3 2025 | $450.3M | -17% |
| Q2 2025 | $481.1M | -6.4% |
| Q1 2025 | $529.6M | 0% |
| Q4 2024 | $577.4M | -6.3% |
| Q3 2024 | $540.4M | -1.8% |
YI's revenue has slid since its 2022 peak: $345M last quarter, down 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1% | -1 points |
| Q1 2026 | -0.8% | -0.8 points |
| Q4 2025 | -0.2% | 0 points |
| Q3 2025 | -0.1% | -0.2 points |
| Q2 2025 | 0% | -0.1 points |
| Q1 2025 | 0% | -0.1 points |
| Q4 2024 | -0.2% | +4.8 points |
| Q3 2024 | 0.1% | +2.3 points |
YI's operating margin was −1% last quarter, down 1 points from the same quarter a year ago.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over YI on cash generation, producing positive trailing cash flow while its opponent burns cash.
YI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.7M | +$7.5M |
| Q1 2026 | -$13.8M | -181% |
| Q4 2025 | $3.8M | +$13.4M |
| Q3 2025 | $5.7M | -65% |
| Q2 2025 | -$9.2M | -166% |
| Q1 2025 | $16.9M | +3.8% |
| Q4 2024 | -$9.6M | +$21.5M |
| Q3 2024 | $16.5M | +212% |
YI has burned cash in most quarters: −$6M over the past year, against $15M the year before.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
YI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -22.3x | Net Cash |
| Q3 2025 | -14.5x | Net Cash |
| Q2 2025 | -14.1x | Net Cash |
| Q1 2025 | -14.0x | Net Cash |
| Q4 2024 | -8.4x | Net Cash |
YI has more cash than debt.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
YI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 13.2 | Oversold |
YI's weekly RSI is 28 (oversold) and its Stochastic is 13 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
YI PE vs Healthcare Sector
YI has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has stronger trend alignment. UNH is above 4 of 5 weekly averages versus YI above 0 of 4.
YI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 7.2% below |
| 20 week MA | $3.47 | 18% below |
| 50 week MA | $4.79 | 41% below |
| 100 week MA | $5.76 | 51% below |
YI is in a downtrend: it's below all four of its weekly moving averages, and 51% below its 100-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over YI on returns for 2026, with the stronger performance.
YI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $11.6 | $7.35 | -36% |
| 2025 | $7.35 | $3.08 | -58% |
| 2026 YTD | $3.08 | $2.85 | -7.5% |
YI has finished every year since 2024 lower, and it's down 7.5% so far in 2026.